{
  "id": 6634,
  "url": "https://nnemf.org/research/6634-risk-factors-for-suboptimal-target-attainment-of-commonly",
  "title": "Risk factors for suboptimal target attainment of commonly used ß-lactam antibiotics in older adults: a prospective cohort study.",
  "authors": [
    "Arnaud De Clercq",
    "Tania Desmet",
    "Jerina Boelens",
    "Annemie Somers",
    "Veronique Stove",
    "Nick Verougstraete",
    "Astrid Brys",
    "Mirko Petrovic",
    "Peter De Paepe",
    "Pieter A De Cock"
  ],
  "journal": "The Journal of antimicrobial chemotherapy",
  "year": "2026",
  "doi": "10.1093/jac/dkag048",
  "pmid": "41692875",
  "abstract": "OBJECTIVES: Age-related pathophysiological changes may impact the pharmacokinetics and pharmacodynamics (PK/PD) of ß-lactam antibiotics, potentially resulting in suboptimal concentrations in older adults. This study evaluated PK/PD target attainment with current intravenous amoxicillin-clavulanate and piperacillin-tazobactam dosing regimens in older adults, identified risk factors for target non-attainment, and assessed the prevalence of toxic concentrations. METHODS: This was a prospective, observational PK study in geriatric inpatients (≥75 years) who were treated intravenously with amoxicillin-clavulanate (1 g/0.2 g q6h as a 30-minute infusion) or piperacillin-tazobactam (4 g/0.5 g q6h as a 3-hour infusion). Trough blood samples were collected in steady-state conditions. Target attainment was evaluated against a 100%fT > MIC target. Risk factors for target non-attainment were identified by multivariable logistic regression analysis. Toxicity thresholds were defined as total Cmin concentrations of 80 mg/L for amoxicillin and 157.2 mg/L for piperacillin. RESULTS: Seventy-four patients (median age (IQR): 87 years (83-90)) were included. The PK/PD target was achieved in 15 of 35 and 33 of 39 patients for amoxicillin-clavulanate and piperacillin-tazobactam, respectively. Multivariable logistic regression analysis revealed an effect of comorbidity burden, assessed by the Cumulative Illness Rating Scale-Geriatric (CIRS-G), and estimated glomerular filtration rate that explained 23.8% of target non-attainment (P < 0.05). Receiver operator characteristic curves identified an eGFR of 67 mL/min/1.73m2 as a threshold associated with an increased risk of target non-attainment. Toxicity thresholds were never exceeded in this study. CONCLUSIONS: Health status and renal function, rather than chronological age, play a significant role in target non-attainment among older adults. Further research is required to delineate predictors for interpatient variability in PK and develop evidence-based dosing strategies. TRIAL REGISTRATION: Registration in ClinicalTrials.govTrial registration number: NCT04436991Registration date: 16/06/2020.",
  "effect": "unclear",
  "evidence": "insufficient",
  "extraction": {
    "studyType": "cohort",
    "studyTypeLabel": "cohort",
    "effectDirection": "unclear",
    "evidenceLabel": "Insufficient",
    "population": "Geriatric inpatients (≥75 years) treated intravenously with amoxicillin-clavulanate or piperacillin-tazobactam",
    "sampleSize": "74",
    "exposure": "",
    "confidencePct": "66",
    "peerReviewed": "yes",
    "mainFindings": "Among 74 geriatric inpatients (median age 87 years), the 100% fT>MIC PK/PD target was achieved in 15/35 patients receiving amoxicillin-clavulanate and 33/39 receiving piperacillin-tazobactam. Comorbidity burden (CIRS-G) and estimated glomerular filtration rate were associated with target non-attainment (model explained 23.8%; P<0.05), with an eGFR threshold of 67 mL/min/1.73m2 linked to increased risk. Toxicity thresholds were not exceeded.",
    "outcomes": [
      "PK/PD target attainment (100% fT>MIC)",
      "Risk factors for PK/PD target non-attainment (multivariable logistic regression)",
      "Prevalence of toxic concentrations (Cmin thresholds for amoxicillin and piperacillin)"
    ],
    "limitations": [],
    "keywords": [
      "older adults",
      "geriatric inpatients",
      "beta-lactam antibiotics",
      "amoxicillin-clavulanate",
      "piperacillin-tazobactam",
      "pharmacokinetics",
      "pharmacodynamics",
      "target attainment",
      "fT>MIC",
      "renal function",
      "eGFR",
      "CIRS-G",
      "toxicity threshold",
      "prospective observational study"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"cohort\",\n  \"exposure\": {\n    \"band\": null,\n    \"source\": null,\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Geriatric inpatients (≥75 years) treated intravenously with amoxicillin-clavulanate or piperacillin-tazobactam\",\n  \"sample_size\": 74,\n  \"outcomes\": [\n    \"PK/PD target attainment (100% fT>MIC)\",\n    \"Risk factors for PK/PD target non-attainment (multivariable logistic regression)\",\n    \"Prevalence of toxic concentrations (Cmin thresholds for amoxicillin and piperacillin)\"\n  ],\n  \"main_findings\": \"Among 74 geriatric inpatients (median age 87 years), the 100% fT>MIC PK/PD target was achieved in 15/35 patients receiving amoxicillin-clavulanate and 33/39 receiving piperacillin-tazobactam. Comorbidity burden (CIRS-G) and estimated glomerular filtration rate were associated with target non-attainment (model explained 23.8%; P<0.05), with an eGFR threshold of 67 mL/min/1.73m2 linked to increased risk. Toxicity thresholds were not exceeded.\",\n  \"effect_direction\": \"unclear\",\n  \"limitations\": [],\n  \"evidence_strength\": \"insufficient\",\n  \"confidence\": 0.66,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"older adults\",\n    \"geriatric inpatients\",\n    \"beta-lactam antibiotics\",\n    \"amoxicillin-clavulanate\",\n    \"piperacillin-tazobactam\",\n    \"pharmacokinetics\",\n    \"pharmacodynamics\",\n    \"target attainment\",\n    \"fT>MIC\",\n    \"renal function\",\n    \"eGFR\",\n    \"CIRS-G\",\n    \"toxicity threshold\",\n    \"prospective observational study\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/41692875/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=6634",
  "updated": "2026-02-17 03:52:58"
}